Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004591431 | SCV000573544 | uncertain significance | not provided | 2024-05-05 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV002350078 | SCV002641629 | uncertain significance | Cardiovascular phenotype | 2023-02-23 | criteria provided, single submitter | clinical testing | The c.536G>C (p.G179A) alteration is located in exon 1 (coding exon 1) of the ZNF469 gene. This alteration results from a G to C substitution at nucleotide position 536, causing the glycine (G) at amino acid position 179 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002489176 | SCV002775643 | uncertain significance | Brittle cornea syndrome 1 | 2021-09-21 | criteria provided, single submitter | clinical testing |